Grantham, Mayo, Van Otterloo & Co (GMO)’s Salesforce CRM Stock Holding History
Bought
Maintained
Sold
Other funds holding CRM
Grantham, Mayo, Van Otterloo & Co (GMO)'s CRM Position: Q2 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) increased its Salesforce (CRM) stake by 0.05% in Q2 2026, buying an estimated $419K and bringing the position to 4,427,933 shares worth $694M. The position accounts for 1.56% of the portfolio, ranked #22.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CRM in Q3 2020 and has held it in 24 quarters since. The position peaked at $1.09B in Q4 2025. 2,479 funds tracked by Wall St. Rank hold CRM as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 4,427,933 shares of Salesforce worth $694M as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) bought 2,381 Salesforce shares in Q2 2026, an estimated $419K.
- Salesforce made up 1.56% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #22 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Salesforce in Q3 2020 and has held it in 24 quarters since.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Salesforce position peaked at $1.09B in Q4 2025.
- 2,479 funds tracked by Wall St. Rank held Salesforce as of Q2 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.